Anti Asthma Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Asthma is a condition of lung in which the airway gets narrow which leads to swelling and production of extra mucus which obstructs airway and triggers coughing as well as shortness of breath. Asthma is a slow growing infection of lungs but can be life threatening if not treated. The asthma is not cured completely only its symptoms can be managed. The symptoms of asthma include, shortness of breath, chest pain, prolonged coughing, and wheezing sound. Asthma drugs includes series of drugs such as, bronchodilators, mast cell stabilizers, corticosteroids.

MARKET DYNAMICS

The key market drivers for Anti-Asthma Drugs Market Includes, rising prevalence of asthma and other lung related disorders, increased exposure to pollution and chemical environment. Moreover, increasing awareness in people about asthma and its treatment is also expected to fuel the market growth. Additionally, strong pipeline of drugs for asthma along with novel therapies to treat lung and related disorders is also expected to boost market growth during the forecast period. Whereas, expiration of patents of branded drugs and introduction of generic version of medicine is the major restraining factor for the market.

MARKET SCOPE

The "Anti-Asthma Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-Asthma Drugs market with detailed market segmentation by type of asthma, asthma trigger type, drug class and route of administration. The Anti-Asthma Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Anti-Asthma Drugs Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Anti-Asthma Drugs Market is segmented on the basis of type of asthma, asthma trigger type, drug class and route of administration. On the basis of asthma type the market is segmented as, allergic and non-allergic. On the basis of asthma trigger type market is segmented as, child onset asthma, adult onset asthma, exercise induced asthma, cough induced asthma, occupational asthma. On the basis of drug class the market is segmented as, bronchodilators, leukotriene antagonists, mast cell stabilizers, corticosteroids, monoclonal antibody. And on the basis of route of administration the market is segmented as, oral, inhaled, intravenous, and subcutaneous.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Anti-Asthma Drugs Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-Asthma Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anti-Asthma Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Asthma Drugs Market in these regions.

Anti Asthma Drugs Market Report Analysis

Anti Asthma Drugs Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• GlaxoSmithKline plc.
• Merck and Co., Inc.
• AstraZeneca plc.
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceutical Industries
• Novartis International AG
• Boehringer Ingelheim
• Sunovion Pharmaceuticals Inc
• Pfizer, Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Type of Asthma

• Allergic
• Non- allergic

By Asthma trigger type

• Child-Onset Asthma
• Adult-Onset Asthma
• Exercise-Induced Asthma
• Cough-Induced Asthma
• Occupational Asthma
• Nocturnal Asthma
• Steroid-Resistant Asthma

By Drug Class

• Bronchodilators
• Leukotriene Antagonists
• Mast Cell Stabilizers
• Corticosteroids
• Monoclonal Antibody

By Route of Administration

• Oral
• Inhaled
• Intravenous
• Subcutaneous

MARKET PLAYERS

The report covers key developments in the Anti-Asthma Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anti-Asthma Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Anti-Asthma Drugs market in the global market. Below mentioned is the list of few companies engaged in the Anti-Asthma Drugs Market.

The report also includes the profiles of key players in Anti-Asthma Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

•   GlaxoSmithKline Plc.
  
•   Boehringer Ingelheim GmbH
  
•   Merck and Co., Inc.
  
•   AstraZeneca Plc.
  
•   F. Hoffmann- La Roche AG
  
•   Novartis International AG
  
•   Pfizer Inc.
  
•   Sunovion Pharmaceuticals, Inc.
  
•   Teva Pharmaceutical Industries Ltd.
  
•   Abbott Laboratories
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Anti Asthma Drugs Market Report Scope